Past investments

• FoRx Therapeutics
• Santaris Pharma
• Spruce Biosciences
• Attenua
• Syros Pharmaceuticals
• Jounce Therapeutics
• Hydrocision
• Atea Pharmaceuticals
• Develogen AG
• eTheRNA immunotherapies
• LEXEO Therapeutics
• Telesta Therapeutics
• Prevail Therapeutics
• Nuvation Bio
• Editas Medicine
• Ardana Bioscience
• Orqis Medical
• XTuit Pharmaceuticals
• Scorpion Therapeutics
• Alpine Immune Sciences
• GelSight
• Dicerna Pharmaceuticals
• First Wave Bio
• Morphic Therapeutic
• Sana Biotechnology
• Adagio Therapeutics
• Intarcia Therapeutics
• Eurobio-Scientific
• Andrew Alliance
• ImpactRx
• BioSilta
• Ikena Oncology
• ESSA Pharma
• Celletra
• Median Technologies
• Translate Bio
• CropDesign
• CymaBay Therapeutics
• Exenta, Inc.
• Neurotech
• Aquarius Technologies
• Replimune Group
• Elixir Pharmaceuticals
• Checkmate Pharmaceuticals
• Imago BioSciences
• Icosavax
• Visterra
• SpineVision
• Achaogen
• OnPath Technologies
• Amunix
• Kronos Bio
• Immunic
• Gossamer Bio
• Anaconda BioMed
• Kuros Biosciences
• JenaValve Technology
• Trevi Therapeutics
• Egalet
• Paratek Pharmaceuticals
• Arrakis Therapeutics
• DBV Technologies
• Kezar Life Sciences
• Sienna Biopharmaceuticals
• Oxagen
• Evotec
• Beam Therapeutics
• Senti Biosciences
• IFM Therapeutics
• Chord Therapeutics
• Endeavor BioMedicines
• ObsEva
• Arcutis Biotherapeutics
• NeuroVision Imaging